The Value of ABCD2F Scoring System (ABCD2 Combined with Atrial Fibrillation) to Predict 90-Day Recurrent Brain Stroke.

Conclusion. ABCD2 and/or atrial fibrillation are not good scoring candidates for assessing the risk of recurrent stroke within first 90 days. PMID: 27642521 [PubMed]
Source: Neurology Research International - Category: Neurology Tags: Neurol Res Int Source Type: research

Related Links:

ConclusionBetween 2011 and 2016, the use of guideline-conform antithrombotic therapy in Germany has significantly increased. This was associated with a significant decline in strokes without an increased incidence of bleeding complications.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
Atrial fibrillation (AF) is one of the most prevalent sustained arrhythmias, however, epidemiological data may understate its actual prevalence. Meanwhile, AF is considered to be a major cause of ischemic stro...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Research Source Type: research
Atrial fibrillation (AF) is present in 15 –20% of patients with acute ischemic stroke. Oral anticoagulation reduces the risk of AF-related recurrent stroke but clinical guideline recommendations are rather vagu...
Source: BMC Neurology - Category: Neurology Authors: Tags: Research article Source Type: research
We read with interest the study by Lehtola et al.1 Anticoagulation (AC) in atrial fibrillation (AF) reduces the risk of ischemic stroke, but at the cost of increasing the risk of hemorrhagic stroke.
Source: Neurology Clinical Practice - Category: Neurology Authors: Tags: The Nerve! Readers Speak Source Type: research
ConclusionsIn Japan, physicians who attempt stroke prevention in patients with atrial fibrillation choose appropriate anticoagulant treatment, taking into consideration the individual patient backgrounds as well as the features of each antithrombotic agent.Trial RegistrationClinicalTrials.gov Identifier, NCT01491178 and University Hospital Medical Information Network (UMIN) Clinical Trial Registry Identifier, UMIN000009644.FundingNippon Boehringer Ingelheim Co., Ltd.Plain Language SummaryPlain language summary available for this article.
Source: Cardiology and Therapy - Category: Cardiology Source Type: research
Authors: Papakonstantinou PE, Simantirakis EN Abstract Although atrial fibrillation (AF) is an arrhythmia with a variable clinical profile (symptomatic and asymptomatic episodes), the first symptomatic episode leads to its initial diagnosis in most cases. Nowadays, continuous and remote long- term cardiac rhythm monitoring is feasible by the use of implantable loop recorders. The data concerning the AF recurrences and progression after the first ECG- documented clinical AF episode demonstrates that a high percentage of patients may not suffer any other AF recurrence, or may present a low recurrence rate of the arrh...
Source: Minerva Cardioangiologica - Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
CONCLUSIONS: The present results are indicative of the favorable benefit-risk profile of dabigatran in Japanese clinical practice. Dabigatran dose was not independently associated with thromboembolic and bleeding events in Japanese NVAF patients. PMID: 30737182 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - Category: Cardiology Authors: Tags: J Cardiol Source Type: research
Publication date: Available online 2 February 2019Source: Canadian Journal of CardiologyAuthor(s): Ting-Yung Chang, Gregory Y.H. Lip, Shih-Ann Chen, Tze-Fan ChaoAbstractThe appropriate use of oral anticoagulants (OACs) for stroke prevention in atrial fibrillation (AF) relies on the convenient and accurate stroke risk prediction scheme, namely the CHA2DS2-VASc score. Since AF patients would become older and accumulate more comorbidities, their risk (for example, as reflected by the CHA2DS2-VASc scores) are not static and could increase over time. The available data demonstrated that follow-up and delta CHA2DS2-VASc scores p...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
AbstractPurposePatients with atrial fibrillation (AF) undergoing cardiac surgery are at substantially increased risk for stroke. Increasing evidence has suggested that surgical left atrial appendage occlusion (S-LAAO) may have the potential to substantially mitigate this stroke risk; however, S-LAAO is performed in a minority of patients with AF undergoing cardiac surgery. We sought to identify factors associated with usage of S-LAAO.MethodsIn a nationally-representative, contemporary cohort (07/2011 –06/2012) of older patients undergoing cardiac surgery with preoperative AF (n = 11,404) from the Medica...
Source: Journal of Interventional Cardiac Electrophysiology - Category: Cardiology Source Type: research
Apple has been in the news recently regarding innovations with iPhones in partnership with hospitals (see:Apple Has Plans to Copy EHR Records to iPhones and Apple Watches) and with health insurance about the Apple Watch (see:Apple Watch"Gifted" to Insurance Policy Holders; Any Gotcha's with the Deal?). Continuing to expand the functionality of the Apple Watch, the company is now partnering withJanssen Pharmaceuticals, a division of J&J, on a clinical trial (see:Johnson&Johnson partners with Apple to see if Watch can prevent strokes). Below are some of the details, copied from the article:Three y...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Food and Drug Administration Healthcare Information Technology Healthcare Innovations Lab Industry Trends Medical Consumerism Medical Research Preventive Medicine Test Kits and Home Testing Source Type: blogs
More News: Accidents | Atrial Fibrillation | Brain | Emergency Medicine | Ischemic Stroke | Neurology | Stroke | Study